Andersson Niklas, Islander Ulrika, Egecioglu Emil, Löf Elin, Swanson Charlotte, Movérare-Skrtic Sofia, Sjögren Klara, Lindberg Marie K, Carlsten Hans, Ohlsson Claes
Center for Bone Research at the Sahlgrenska Academy, Division of Endocrinology, Department of Internal Medicine, Göteborg University, Gröna stråket 8 SE-413 45 Göteborg, Sweden.
J Endocrinol. 2005 Nov;187(2):303-9. doi: 10.1677/joe.1.06181.
It is generally believed that estrogens exert their bone sparing effects directly on the cells within the bone compartment. The aim of the present study was to investigate if central mechanisms might be involved in the bone sparing effect of estrogens. The dose-response of central (i.c.v) 17beta-estradiol (E2) administration was compared with that of peripheral (s.c.) administration in ovariectomized (ovx) mice. The dose-response curves for central and peripheral E2 administration did not differ for any of the studied estrogen-responsive tissues, indicating that these effects were mainly peripheral. In addition, ovx mice were treated with E2 and/or the peripheral estrogen receptor antagonist ICI 182,780. ICI 182,780 attenuated most of the estrogenic response regarding uterus weight, retroperitoneal fat weight, cortical BMC and trabecular bone mineral content (P<0.05). These findings support the notion that the primary target tissue that mediates the effect of E2 on bone is peripheral and not central.
一般认为,雌激素对骨组织内的细胞直接发挥其保骨作用。本研究的目的是调查中枢机制是否可能参与雌激素的保骨作用。在去卵巢(ovx)小鼠中,比较了中枢(脑室内)给予17β-雌二醇(E2)与外周(皮下)给予的剂量反应。对于任何研究的雌激素反应性组织,中枢和外周给予E2的剂量反应曲线均无差异,表明这些作用主要是外周性的。此外,用E2和/或外周雌激素受体拮抗剂ICI 182,780处理ovx小鼠。ICI 182,780减弱了关于子宫重量、腹膜后脂肪重量、皮质骨矿物质含量(BMC)和小梁骨矿物质含量的大部分雌激素反应(P<0.05)。这些发现支持这样的观点,即介导E2对骨作用的主要靶组织是外周组织而非中枢组织。